Application of cox model in coagulation function in patients with primary liver cancer

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 326-330

  Guo, Xuan ^a   Chen, Mingwei ^a   Ding, Li ^a   Zhao, Shan ^a   Wang, Yuefei ^a   Kang, Qinjiong ^a   Liu, Yi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Coagulation function; Cox proportional hazard model; Liver cancer staging; Primary liver cancer

Indexed keywords

D DIMER; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER CANCER; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTHROMBIN TIME; SURVIVAL TIME; THROMBIN TIME; THROMBOCYTE COUNT;

ADULT; AGED; BLOOD COAGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; THROMBOSIS;

EID: 79958135431     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Vlodavsky I, Ilan N, Nadir Y, Brenner B, Katz BZ, Naggi A, Torri G, Casu B, Sasisekharan R: Heparanase, heparin and the coagulation system in cancer progression. Thromb Res 2007; 120Suppl 2:S112-120.
2. Pulatov DA: [Clinical efficiency of chemotherapy in primary liver cancer depending on the state of blood coagulation system]. Lik Sprava 2002:52-54.
3. Cunningham MS, White B, O'Donnell J: Prevention and management of venous thromboembolism in people with cancer: a review of the evidence. Clin Oncol (R Coll Radiol) 2006; 18:145-151. (Pubitemid 43169144)
4. Zwicker JI, Furie BC, Furie B: Cancer-associated thrombosis. Crit Rev Oncol Hematol 2007; 62:126-136.
5. Franchini M, Montagnana M, Targher G, Manzato F, Lippi G: Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis 2007; 24:29-38. (Pubitemid 46831561)
6. Delis SG, Madariaga J, Bakoyiannis A, Dervenis C: Current role of bloodless liver resection. World J Gastroenterol 2007; 13:826-829. (Pubitemid 46470290)
7. Casoinic F, Sampelean D, Badau C: Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease. Rom J Intern Med 2006; 44:419-426.
8. Aytac S, Turkay C, Bavbek N, Kosar A: Hemostasis and global fibrinolytic capacity in chronic liver disease. Blood Coagul Fibrinolysis 2007; 18:623-626. (Pubitemid 47479412)
9. Belting M, Ahamed J, Ruf W: Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005; 25:1545-1550. (Pubitemid 41098920)
10. Voland C, Serre CM, Delmas P, Clezardin P: Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1. J Bone Miner Res 2000; 15:361-368. (Pubitemid 30095724)
11. Tseng CS, Lo HW, Chen PH, Chuang WL, Juan CC, Ker CG: Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Hepatogastroenterology 2004; 51:1454-1458.
12. Mueller MM, Bomke B, Seifried E: Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res 2002; 107Suppl 1:S9-17.
13. Bromberg ME, Cappello M: Cancer and blood coagulation: molecular aspects. Cancer J Sci Am 1999; 5:132-138. (Pubitemid 29252424)
14. Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van Roon AM, van der Meer J, van den Berg MP, Burgerhof JG, Hoekstra HJ, Sluiter WJ, Gietema JA: Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer 2004; 40:701-706.
15. Saxena V, Mishra DK, Subramanya H, Satyanarayana S, Sharma A: Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases. Indian J Pathol Microbiol 2004; 47:210-212. (Pubitemid 41656615)
16. van Doormaal FF, Buller HR: Heparin and survival in cancer patients. Hematol Oncol Clin North Am 2010; 24:777-784, ix-x.
17. Ritz JP, Lehmann KS, Zurbuchen U, Wacker F, Brehm F, Isbert C, Germer CT, Buhr HJ, Holmer C: Improving laser-induced thermotherapy of liver metastases-effects of arterial microembolization and complete blood flow occlusion. Eur J Surg Oncol 2007; 33:608-615. (Pubitemid 46758869)
18. Spadaro A, Tortorella V, Morace C, Fortiguerra A, Composto P, Bonfiglio C, Alibrandi A, Luigiano C, De Caro G, Ajello A, Ferrau O, Freni MA: High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. World J Gastroenterol 2008; 14:1549-1552. (Pubitemid 351460170)
19. Kim HK, Lee KR, Yang JH, Yoo SJ, Lee SW, Jang HJ, Park SJ, Moon YS, Park JW, Kim CM: Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res 2003; 109:125-129. (Pubitemid 36428763)
20. Ban D, Shimada K, Yamamoto Y, Nara S, Esaki M, Sakamoto Y, Kosuge T: Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg 2009; 13:1921-1928.
21. Corvera CU, Dada SA, Kirkland JG, Garrett RD, Way LW, Stewart L: Bipolar pulse coagulation for resection of the cirrhotic liver. J Surg Res 2006; 136:182-186. (Pubitemid 44737836)
22. Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S: Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002; 131:300-310. (Pubitemid 34229783)